Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jun 15;122(12):1832-5.
doi: 10.1002/cncr.29975. Epub 2016 Apr 8.

Updated results of the Gothenburg Trial of Mammographic Screening

Nils G Bjurstam  1 , Lena M Björneld  1 , Stephen W Duffy  2
Affiliations
Randomized Controlled Trial

Updated results of the Gothenburg Trial of Mammographic Screening

Nils G Bjurstam et al. Cancer. .

Abstract

Background: There remain uncertainties about age-specific effects of breast cancer screening on mortality due to the disease.

Methods: In 1982, a randomized trial of mammographic screening every 18 months was started in Gothenburg, Sweden. Women between the ages of 39 and 49 years were randomized to an invitation to screening (intervention group; n = 11,792) or to usual care (the control group; n = 14,321). The corresponding numbers for women between the ages of 50 and 59 years were 10,112 and 15,997. Follow-up data for breast cancer mortality were available up to the end of 2007. Data were analyzed by Poisson regression with conservative variance estimates.

Results: There were 79 breast cancer deaths in the intervention arm and 156 in the control arm, and this meant a significant 30% reduction in breast cancer mortality with the offer of screening (relative risk [RR], 0.70; 95% confidence interval [CI], 0.53-0.93; P = .01). In women aged 39 to 49 years, there was a significant 40% reduction in breast cancer mortality (RR, 0.60; 95% CI, 0.43-0.85; P = .003). In the 50- to 59-year age group, there was a nonsignificant 18% breast cancer mortality reduction (RR, 0.82; 95% CI, 0.54-1.26; P = .4).

Conclusions: The policy of offering mammographic screening substantially reduces breast cancer mortality and can do so in women younger than 50 years. Cancer 2016;122:1832-5. © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

Keywords: age-specific results; breast cancer; mammography; randomized trial; screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative breast cancer mortality rates over time in the intervention and control arms.
See this image and copyright information in PMC

References

    1. Tabar L, Yen AMF, Wu WYY, et al. Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J. 2015;21:13‐20. - PubMed
    1. Independent UK Panel on Breast Cancer Screening . The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778‐1786. - PubMed
    1. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599‐1614. - PMC - PubMed
    1. Duffy SW, Chen THH, Smith RA, et al. Real and artificial controversies in breast cancer screening. Breast Cancer Manage. 2013;2:519‐528.
    1. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877. - PMC - PubMed

Publication types